Innovent Biologics Receives FDA Clearance to Launch First Global Phase 3 Trial of IBI363 in IO-Resistant Lung Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company committed to developing, manufacturing and commercializing h...

August 25, 2025 | Monday | News
BlossomHill Therapeutics Doses First Patient in SOLARA Trial Expansion of First-in-Class OMNI-EGFR™ Inhibitor

BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines ...

August 25, 2025 | Monday | News
Stanford’s ViRx and Fifty1 AI Labs Forge Alliance to Repurpose Drugs for Pandemic Preparedness

ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: FITY), an innovati...

August 25, 2025 | Monday | News
Terumo Acquires OrganOx in $1.5 Billion Deal to Transform Global Organ Transplantation

- Expanding opportunities for organ transplantation worldwide and contributing to the advancement of transplant medicine - Terumo Corporation announced ...

August 25, 2025 | Monday | News
InnoCare Pharma Begins Registrational Study of Mesutoclax in China, Offering New Hope for Lymphoma Patients Globally

InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has...

August 22, 2025 | Friday | News
Thermo Fisher Opens Carbon-Neutral Manufacturing Center in North Carolina to Boost U.S. Pipette Tip Supply

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the grand opening of its innovative manufacturing center of excellenc...

August 22, 2025 | Friday | News
Agilent MMR IHC Panel pharmDx Wins FDA Approval as Companion Diagnostic for Colorectal Cancer

-Agilent Technologies Inc. announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for ...

August 21, 2025 | Thursday | News
Align Technology Files Global Patent Infringement Lawsuits Against Angelalign

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign...

August 19, 2025 | Tuesday | News
Ryght AI and Biorasi Partner to Transform Clinical Trial Feasibility with AI Digital Twins

Ryght AI, the clinical trials AI technology company transforming site activation and optimization through AI digital twins of every research site in the ...

August 18, 2025 | Monday | News
Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News
Sarepta Advances SRP-1003 for DM1 Triggering $100 Million Milestone Payment to Arrowhead

Safety review leading to dose escalation and achievement of first predetermined enrollment target in Phase 1/2 study of SRP-1003 for DM1 triggers $100 ...

August 14, 2025 | Thursday | News
Rapid Micro Biosystems Secures $45 Million Loan Facility to Accelerate Global Growth of Growth Direct® System

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company” or “Rapid Micro”), an innovative life sciences technology company prov...

August 14, 2025 | Thursday | News
Enable Injections Wins ANVISA Approval for enFuse® On-Body Drug Delivery System in Brazil

Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® on-body drug deliv...

August 14, 2025 | Thursday | News
Insmed Secures FDA Approval for BRINSUPRI™, the First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis

Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung D...

August 14, 2025 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close